TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/NRF2 signaling

被引：0
作者：
Teng Xu
Yuemei Yang
Zhihong Chen
Jinsong Wang
Xiaolei Wang
Yang Zheng
Chao Wang
Yachen Wang
Zaiou Zhu
Xu Ding
Junbo Zhou
Gang Li
Hongchuang Zhang
Wei Zhang
Yunong Wu
Xiaomeng Song
机构：
[1] Nanjing Medical University,Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Stomatology
[2] Nanjing Medical University,Jiangsu Key Laboratory of Oral Diseases
[3] Nanjing Medical University,Jiangsu Province Engineering Research Center of Stomatological Translational Medicine
[4] Nanjing Medical University,Department of Pathology, Nanjing First Hospital
[5] Shanghai Ninth People’s Hospital,Department of Oral Maxillofacial & Head and Neck Oncology
[6] Shanghai Jiao Tong University School of Medicine,Department of Stomatology
[7] National Clinical Research Center of Stomatology,Department of Stomatology
[8] Nanjing Integrated Traditional Chinese and Western Medicine Hospital,undefined
[9] Affiliated Hospital of Xuzhou Medical University,undefined
[10] Department of Stomatology,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 42卷
关键词：
Head and neck squamous cell carcinoma; TNFAIP2; KEAP1/NRF2; Oxidative stress; Cisplatin resistant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Clinical implication of Keap1 and phosphorylated Nrf2 expression in hepatocellular carcinoma
    Chen, Jiang
    Yu, Yaojun
    Ji, Tong
    Ma, Rui
    Chen, Mingming
    Li, Gaofeng
    Li, Feibo
    Ding, Qiong
    Kang, Qingsong
    Huang, Diyu
    Liang, Xiao
    Lin, Hui
    Cai, Xiujun
    CANCER MEDICINE, 2016, 5 (10): : 2678 - 2687
  • [22] Nrf2 activation through the inhibition of Keap1–Nrf2 protein–protein interaction
    Sumi Lee
    Longqin Hu
    Medicinal Chemistry Research, 2020, 29 : 846 - 867
  • [23] Keap1/Nrf2 Signaling: A New Player in Thyroid Pathophysiology and Thyroid Cancer
    Renaud, Cedric O.
    Ziros, Panos G.
    Chartoumpekis, Dionysios, V
    Bongioyanni, Massimo
    Sykiotis, Gerasimos P.
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [24] Nrf2 signaling in heart failure: expression of Nrf2, Keap1, antioxidant, and detoxification genes in dilated or ischemic cardiomyopathy
    Lu, Yingying
    An, Lingling
    Taylor, Matthew R. G.
    Chen, Qin M.
    PHYSIOLOGICAL GENOMICS, 2022, 54 (03) : 115 - 127
  • [25] Keap1/Nrf2/ARE redox-sensitive signaling system as a pharmacological target
    Zenkov, N. K.
    Menshchikova, E. B.
    Tkachev, V. O.
    BIOCHEMISTRY-MOSCOW, 2013, 78 (01) : 19 - 36
  • [26] Epigenetic Therapeutics Targeting NRF2/KEAP1 Signaling in Cancer Oxidative Stress
    Zhang, Shunhao
    Duan, Sining
    Xie, Zhuojun
    Bao, Wanlin
    Xu, Bo
    Yang, Wenbin
    Zhou, Lingyun
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [27] KEAP1 and done? Targeting the NRF2 pathway with sulforaphane
    Dinkova-Kostova, Albena T.
    Fahey, Jed W.
    Kostov, Rumen V.
    Kensler, Thomas W.
    TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2017, 69 : 257 - 269
  • [28] Differential squamous cell fates elicited by NRF2 gain of function versus KEAP1 loss of function
    Takahashi, Jun
    Suzuki, Takafumi
    Sato, Miu
    Nitta, Shuji
    Yaguchi, Nahoko
    Muta, Tatsuki
    Tsuchida, Kouhei
    Suda, Hiromi
    Morita, Masanobu
    Hamada, Shin
    Masamune, Atsushi
    Takahashi, Satoru
    Kamei, Takashi
    Yamamoto, Masayuki
    CELL REPORTS, 2024, 43 (04):
  • [29] Parthenolide inhibits lipid accumulation via activation of Nrf2/Keap1 signaling during adipocyte differentiation
    Kim, Chae Young
    Kang, Bobin
    Hong, Jungil
    Choi, Hyeon-Son
    FOOD SCIENCE AND BIOTECHNOLOGY, 2020, 29 (03) : 431 - 440
  • [30] Role of the Keap1/Nrf2 pathway in neurodegenerative diseases
    Yamazaki, Hiromi
    Tanji, Kunikazu
    Wakabayashi, Koichi
    Matsuura, Shin
    Itoh, Ken
    PATHOLOGY INTERNATIONAL, 2015, 65 (05) : 210 - 219
12345